Biotest AG banner

Biotest AG
DUS:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
DUS:BIO
Watchlist
Price: 42 EUR Market Closed
Market Cap: €1.7B

Wall St Price Targets

BIO Price Targets Summary
Biotest AG

There are no price targets for BIO.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Biotest AG Competitors:
Price Targets
CDNA
CareDx Inc
18% Upside
TTD
Trade Desk Inc
52% Upside
FAST
Fastenal Co
7% Upside

Revenue
Forecast

7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.

Operating Income
Forecast

12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.

Net Income
Forecast

N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate for Net Income over the next 1 year is 121%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BIO's stock price target?
Not Available

BIO does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%

Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.

What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%

Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.

What is the Net Income forecast for Biotest AG?
Projected CAGR
121%

The compound annual growth rate for Net Income over the next 1 year is 121%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett